Financhill
Back

ProPhase Labs Vs. Avidity Biosciences Industry Stock Comparison

Sell
31

PRPH
ProPhase Labs

Last Price:
2.45
Seasonality Move:
20.16%
Sell
31

RNA
Avidity Biosciences

Last Price:
45.67
Seasonality Move:
-1.3%
Sell
31
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $2.45. The Score for PRPH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $44.64. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $2.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $44.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: -38684 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.77) Sell
Bollinger Bands (100): (2.71 - 4.81) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 58.78 Buy
Chaikin Money Flow: 2358339 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.17 - 44.49) Buy
Bollinger Bands (100): (30.01 - 45.23) Buy

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.59 Sell
20-day SMA: 2.58 Sell
50-day SMA: 2.8 Sell
200-day SMA: 4.48 Sell
8-day EMA: 2.55 Sell
20-day EMA: 2.6 Sell
50-day EMA: 2.94 Sell
200-day EMA: 4.29 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.71 Buy
20-day SMA: 42.36 Buy
50-day SMA: 43.76 Buy
200-day SMA: 26.77 Buy
8-day EMA: 42.29 Buy
20-day EMA: 42.39 Buy
50-day EMA: 41.68 Buy
200-day EMA: 30.34 Buy

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):